Back to Results
First PageMeta Content
Health / Sleep apnea / Central sleep apnea / Polysomnography / Hypopnea / Sleep and breathing / Sleep / Heart failure / Nasal EPAP / Sleep disorders / Medicine / Biology


A Randomized Trial Evaluating the Safety and Effectiveness of the remedē® System in Patients with Central Sleep Apnea (CSA) International Principal Investigator: Maria Rosa Costanzo, MD Why Should Central Sleep Apnea b
Add to Reading List

Document Date: 2013-10-11 23:04:45


Open Document

File Size: 4,35 MB

Share Result on Facebook

Country

United States / /

IndustryTerm

cardiac resynchronization device / medical management / implantable transvenous device / /

MedicalCondition

apnea hypopnea index / System Pivotal Trial Inclusion/Exclusion Criteria Primary Effectiveness Endpoint Key Inclusion Criteria Central Sleep Apnea / severe central sleep apnea / Recent heart failure / myocardial infarction / heart failure / Why Should Central Sleep Apnea / daytime fatigue / central apnea events Obstructive apneas / apneas / Central Sleep Apnea / /

MedicalTreatment

surgery / bypass / /

Person

Maria Rosa Costanzo / /

Position

International Principal Investigator / /

URL

www.respicardia.com / www.clinicaltrials.gov / /

SocialTag